US Patent Issued to CepVentures International, LIV INNOVATION on March 3 for "Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight" (Swiss Inventor)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,599, issued on March 3, was assigned to CepVentures International Corp. (Anguilla, Anguilla) and LIV INNOVATION SA (Lugano, Switzerland).

"Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight" was invented by Ronald Johannes Glas (Lugano, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition comprising a tetrahydrocannabivarin (THCV), wherein the composition further comprises cannabigerol (CBG) or cannabinodiol (CBND) or a mixture thereof, for use in the prevention and treatment of overweight, preferably associated with obesitas....